Israel Englander Guardant Health, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,135,311 shares of GH stock, worth $54.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,135,311

Previous 14,600 14525.42%

Holding current value

$54.2 Million

Previous $301,000 20387.38%

% of portfolio

0.03%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $15.2 Million - $30.1 Million	945,328 Added 79.44%	2,135,311 $61.7 Million
Q1 2024 May 15, 2024	BUY	$17.13 - $26.91 $8.05 Million - $12.6 Million	469,968 Added 65.27%	1,189,983 $24.5 Million
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $37 Million - $50.6 Million	-1,714,163 Reduced 70.42%	720,015 $19.5 Million
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $23.8 Million - $43.2 Million	1,136,756 Added 87.62%	2,434,178 $87.1 Million
Q1 2023 May 15, 2023	BUY	$22.92 - $33.76 $16.1 Million - $23.7 Million	702,866 Added 118.22%	1,297,422 $30.4 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $15.1 Million - $35.5 Million	594,556 New	594,556 $16.2 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $176,868 - $474,696	-6,137 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $1.37 Million - $2.85 Million	-28,409 Reduced 82.24%	6,137 $407,000
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $2.25 Million - $3.06 Million	-25,404 Reduced 42.38%	34,546 $3.46 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $23.6 Million - $31.6 Million	-239,359 Reduced 79.97%	59,950 $7.49 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $5.24 Million - $7.91 Million	-47,753 Reduced 13.76%	299,309 $37.2 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $10.4 Million - $14.7 Million	82,112 Added 30.99%	347,062 $53 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $6.4 Million - $8.71 Million	64,043 Added 31.88%	264,950 $34.1 Million
Q3 2020 Nov 16, 2020	SELL	$80.32 - $111.8 $9.83 Million - $13.7 Million	-122,363 Reduced 37.85%	200,907 $22.5 Million
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $19.6 Million - $31.5 Million	323,270 New	323,270 $26.2 Million
Q1 2020 May 14, 2020	SELL	$59.04 - $88.81 $19.8 Million - $29.7 Million	-334,704 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$59.49 - $82.78 $12.3 Million - $17.1 Million	207,105 Added 162.31%	334,704 $26.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $4.17 Million - $7.35 Million	-66,676 Reduced 34.32%	127,599 $8.14 Million
Q2 2019 Aug 15, 2019	BUY	$63.94 - $91.11 $6.74 Million - $9.6 Million	105,347 Added 118.46%	194,275 $16.8 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $5.69 Million - $8.1 Million	88,928 New	88,928 $992,000

Others Institutions Holding GH

# of Institutions

331

Shares Held

116M

Call Options Held

680K

Put Options Held

1.66M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.6B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account